US 10337005
Oligonucleotide-based inhibitors comprising locked nucleic acid motif
granted A61PA61P9/00A61P9/04
Quick answer
US patent 10337005 (Oligonucleotide-based inhibitors comprising locked nucleic acid motif) held by MIRAGEN THERAPEUTICS, INC. expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MIRAGEN THERAPEUTICS, INC.
- Grant date
- Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P9/00, A61P9/04, A61P9/10